Patent · US Active

Polymerases for nucleotide analogue incorporation

US9951321B2 · kind B2 · utility

1Cited by
20References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 6, 2016
Grant dateApr 24, 2018
Priority date
Expiry dateDec 6, 2036

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02P20/52
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Compositions that include polymerases with features for improving entry of nucleotide analogs into active site regions and for coordinating with the nucleotide analogs in the active site region are provided. Methods of making the polymerases and of using the polymerases in sequencing and DNA replication and amplification as well as kinetic models of polymerase activity and computer-implemented methods of using the models are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.